These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18082284)

  • 1. Short-term reproducibility of impaired fasting glycaemia, impaired glucose tolerance and diabetes The ADDITION study, DK.
    Rasmussen SS; Glümer C; Sandbaek A; Lauritzen T; Carstensen B; Borch-Johnsen K
    Diabetes Res Clin Pract; 2008 Apr; 80(1):146-52. PubMed ID: 18082284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence From a Systematic Review and Meta-Analysis: Classical Impaired Glucose Tolerance Should Be Divided Into Subgroups of Isolated Impaired Glucose Tolerance and Impaired Glucose Tolerance Combined With Impaired Fasting Glucose, According to the Risk of Progression to Diabetes.
    Liu Y; Li J; Wu Y; Zhang H; Lv Q; Zhang Y; Zheng X; Tong N
    Front Endocrinol (Lausanne); 2022; 13():835460. PubMed ID: 35250886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
    Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is using WHO criteria for impaired fasting glycaemia appropriate as an indication for OGTT in patients at high risk of developing diabetes?
    Sulaiman RA; Labib MH
    Int J Clin Pract; 2010 Dec; 64(13):1793-5. PubMed ID: 21117282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries.
    Priya M; Mohan Anjana R; Pradeepa R; Jayashri R; Deepa M; Bhansali A; Mohan V
    Diabetes Technol Ther; 2011 May; 13(5):586-91. PubMed ID: 21406012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
    Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
    Unwin N; Shaw J; Zimmet P; Alberti KG
    Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance.
    Hellgren MI; Daka B; Jansson PA; Lindblad U
    Prim Care Diabetes; 2015 Aug; 9(4):261-6. PubMed ID: 25466159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired fasting glucose and impaired glucose tolerance - lack of agreement between the two categories in a North Indian population.
    Zargar AH; Masoodi SR; Khan AK; Bashir MI; Laway BA; Wani AI; Dar FA
    Diabetes Res Clin Pract; 2001 Feb; 51(2):145-9. PubMed ID: 11165694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral glucose tolerance testing as a complement to fasting plasma glucose in screening for type 2 diabetes: population-based cross-sectional analyses of 146 000 health examinations in Västerbotten, Sweden.
    Rosén A; Otten J; Stomby A; Vallin S; Wennberg P; Brunström M
    BMJ Open; 2022 Jun; 12(6):e062172. PubMed ID: 35676014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.